Jazz-linked lurbinectedin GI trial posts results; new JZP269 Phase 1 study registeredSep 11Weekly roundup, 2 itemsJazz PharmaceuticalsJZP269
Trinity Biotech's Trinovium unit partners with Echelon on AI data center coolingAug 17PartnershipTrinity Biotech Plc
Acumen reports Q2 2026 results, reaffirms ALTITUDE-AD readout for late 2026Aug 12Clinical readoutAcumen Pharmaceuticals
SIGA reports $37 million in TPOXX sales for second quarter of 2026Aug 6Quarterly updateSIGA Technologiestecovirimat
Voyager reports Q2 2026 results, sets Q4 milestones for two Alzheimer's programsAug 6Quarterly updateVoyager TherapeuticsVY1706
Generate Biomedicines reports Q2 2026 results, advances asthma and oncology pipelineAug 6Quarterly updateGenerate Biomedicines
QuidelOrtho cuts full-year 2026 guidance on China pricing pressureAug 6Quarterly updateQuidelOrtho Corp
IDEXX reports second quarter revenue growth of 10%, raises full year outlookAug 4Quarterly updateIdexx Laboratories Inc /De
Tonix says FDA aligns on Phase 2 design for Lyme antibody TNX-4800Aug 3Quarterly updateTonix Pharmaceuticals, Inc.
Jazz Pharmaceuticals reports 2Q26 results, raises 2026 revenue guidanceAug 3Quarterly updateJazz Pharmaceuticalszanidatamab-hrii
Sign inSign in